Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

Bronchodilators Don't Improve Smoking-Related Respiratory Symptoms in People Without COPD Sep. 5, 2022 — Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

Seek expert support for respiratory issues from pulmonologists. Learn how they diagnose and manage lung diseases for better ...